Q4 2025 OptimizeRx Corp Earnings Call Transcript
Key Points
- OptimizeRx Corp (OPRX) delivered a strong fourth quarter, exceeding both consensus estimates and internal expectations with revenue of $32.2 million and adjusted EBITA of $12 million.
- For the full year 2025, the company achieved revenue of $109.4 million and adjusted EBITA of $24.3 million, demonstrating the strength of its operating model.
- The company saw improvements in product mix and channel partner strategy, contributing to higher gross margins in 2025.
- OptimizeRx Corp (OPRX) more than doubled both adjusted EBITA and free cash flow year over year, showcasing the benefits of its scalable operating model.
- The board authorized a $10 million share repurchase program, reflecting confidence in the long-term value of the business.
- There is softness in year-to-date contracted revenue numbers compared to last year, driven by a market shift away from managed services.
- Some clients are adopting a more conservative spending tone in early 2026, impacting revenue expectations.
- The company updated its 2026 guidance with a more conservative revenue outlook, expecting revenue between $109 million and $114 million.
- Gross margins in 2026 are expected to be in the mid-60% range, lower than the record gross margin quarter in Q4 2025.
- The company is experiencing shorter contract durations, impacting the predictability of revenue streams.
Good afternoon, everyone, and thank you for joining Optimize RX's 4th quarter and fiscal 2025 earnings conference call. With us today is Chief Executive Officer, Steve Silvestro. He is joined by Chief Financial and Strategic Officer Ed Stelmach, Chief Legal and Administrative Officer, Marion Odden Ford, and Chief Business Officer, Andrew DeSilva.
At the conclusion of today's call, I will provide some important cautions regarding the forward-looking statements made by management during today's call.
The company will also be discussing certain non-GAAP financial measures which it believes are useful in evaluating the company's operating results. A reconciliation of such non-GAAP financial measures is included in the earnings release the company issued this afternoon, as well as in the investor relations section of the company's website.
I would like to remind everyone that today's call is being recorded and will be made available for replay as an audio recording of this conference call on the investor relations section of the company's website.
Now I would like to turn
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
